Return to Article Details
CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma
Download
Download PDF
Themes by Openjournaltheme.com
Themes by Openjournaltheme.com